KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GALT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Galectin Therapeutics Inc. stock price on Thursday moving between $3.20 and $3.55
(Updated on Apr 25, 2024)

Buy or Hold candidate since Feb 27, 2024 Gain 88.17% PDF

The Galectin Therapeutics Inc. stock price gained 6.38% on the last trading day (Thursday, 25th Apr 2024), rising from $3.29 to $3.50. During the last trading day the stock fluctuated 10.94% from a day low at $3.20 to a day high of $3.55. The price has fallen in 7 of the last 10 days and is down by -16.67% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 50 thousand more shares were traded than the day before. In total, 212 thousand shares were bought and sold for approximately $741.20 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 96.05% during the next 3 months and, with a 90% probability hold a price between $5.93 and $8.94 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GALT Signals & Forecast

The Galectin Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.34 and $2.85. A breakdown below any of these levels will issue sell signals. Galectin Therapeutics Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, April 11, 2024, and so far it has fallen -16.67%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Galectin Therapeutics Inc. stock

Galectin Therapeutics Inc. finds support from accumulated volume at $3.40 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.350 between high and low, or 10.94%. For the last week, the stock has had daily average volatility of 11.91%.

Our recommended stop-loss: $3.29 (-6.10%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 10 days ago.)

Trading Expectations (GALT) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Galectin Therapeutics Inc. to open at $3.42, and during the day (based on 14 day Average True Range), to move between $3.18 and $3.82, which gives a possible trading interval of +/-$0.319 (+/-9.11%) up or down from last closing price. If Galectin Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 18.22% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.40 (2.86%) than the resistance at $3.73 (6.57%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Galectin Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Galectin Therapeutics Inc. stock to perform well in the short-term.

Current score: 2.719 Buy Candidate Unchanged

Predicted Opening Price for Galectin Therapeutics Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$3.42 ( 2.38%) $3.50

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GALT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.77 7.62 %
R2 3.63 3.80 %
R1 3.55 1.44 %
Current price: 3.50
Support S1 3.28 -6.20 %
S2 3.20 -8.56 %
S3 3.07 -12.38 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.97 13.43 %
R2 3.82 9.14 %
R1 3.73 6.57 %
Current price 3.50
Support S1 3.40 -2.86%
S2 3.38 -3.43%
S3 2.85 -18.57%

FAQ

What is the symbol for Galectin Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Galectin Therapeutics Inc. is GALT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Galectin Therapeutics Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Galectin Therapeutics Inc. stock to perform well in the short-term.

How to buy Galectin Therapeutics Inc. Stock?
Galectin Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Galectin Therapeutics Inc. Stock.

What's the current price of Galectin Therapeutics Inc. Stock?
As of the end of day on the Apr 25, 2024, the price of an Galectin Therapeutics Inc. (GALT) share was $3.50.

What is the 52-week high and low for Galectin Therapeutics Inc. Stock?
The 52-week high for Galectin Therapeutics Inc. Stock is $4.27 and the 52-week low is $1.28.

What is the market capitalization of Galectin Therapeutics Inc. Stock?
As of the Apr 25, 2024, the market capitalization of Galectin Therapeutics Inc. is 216.663M.

When is the next earnings date for Galectin Therapeutics Inc.?
The upcoming earnings date for Galectin Therapeutics Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Galectin Therapeutics Inc.

Galectin Therapeutics. Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatiti... GALT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT